Ochoa Chaar Cassius I, Shebl Fatma, Sumpio Bauer, Dardik Alan, Indes Jeffrey, Sarac Timur
Section of Vascular Surgery, Department of Surgery, Yale School of Medicine, New Haven, Conn.
Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Conn.
J Vasc Surg. 2017 Jul;66(1):143-150. doi: 10.1016/j.jvs.2017.01.032. Epub 2017 Mar 30.
Distal embolization (DE) during peripheral arterial endovascular interventions is a well-known complication that is poorly studied. The goal of this study was to determine the incidence, risk factors, and effect of DE on the outcomes of lower extremity endovascular interventions (LEIs).
All LEIs between 2010 and 2014 in the Vascular Study Group of New England (VSGNE) database were reviewed. Patient characteristics were analyzed to determine predictors of DE. LEIs involving the superficial femoral artery (SFA) were reviewed to assess the effect of type of treatment on DE. The outcomes examined were loss of patency, limb loss, and mortality after LEI involving the SFA. A multivariable regression was used to determine predictors of DE.
There were 10,875 procedures. The incidence of DE was 17.3 per 1000 procedures, and 68% required treatment (57% endovascular, 11% open surgery). DE was more common in patients treated for critical limb ischemia compared with claudication (relative risk [RR], 2.06; 95% confidence interval [CI], 1.24-3.45; P = .006) and for emergency interventions compared with elective (RR, 2.98; 95% CI, 1.22-7.30; P = .017). DE increased with the number of arteries treated (P < .0001) and with the length of occlusion (P < .0001). The SFA was the most commonly treated artery (4751 [43.7%]). In comparison with atherectomy and balloon angioplasty, stenting alone (RR, 0.36; 95% CI, 0.17-0.73; P = .005), balloon angioplasty alone (RR, 0.23; 95% CI, 0.13-0.41; P < .0001), and combined stenting and balloon angioplasty (RR, 0.29; 95% CI, 0.17-0.49; P < .0001) were associated with a significantly lower risk of DE. DE was not significantly associated with loss of patency, major amputation, or mortality.
The incidence of DE during LEIs is 1% to 2% in the VSGNE database, and most patients are treated with additional endovascular interventions. The incidence increases in patients with critical limb ischemia and with the use of atherectomy.
外周动脉血管内介入治疗期间的远端栓塞(DE)是一种已知但研究较少的并发症。本研究的目的是确定DE的发生率、危险因素及其对下肢血管内介入治疗(LEI)结局的影响。
回顾了新英格兰血管研究组(VSGNE)数据库中2010年至2014年期间的所有LEI。分析患者特征以确定DE的预测因素。对涉及股浅动脉(SFA)的LEI进行回顾,以评估治疗类型对DE的影响。所检查的结局包括涉及SFA的LEI后的通畅性丧失、肢体缺失和死亡率。采用多变量回归确定DE的预测因素。
共进行了10875例手术。DE的发生率为每1000例手术17.3例,68%的患者需要治疗(57%为血管内治疗,11%为开放手术)。与间歇性跛行患者相比,严重肢体缺血患者发生DE更为常见(相对风险[RR],2.06;95%置信区间[CI],1.24 - 3.45;P = 0.006),与择期手术相比,急诊手术发生DE更为常见(RR,2.98;95%CI,1.22 - 7.30;P = 0.017)。DE的发生率随治疗动脉数量的增加而增加(P < 0.0001),也随闭塞长度的增加而增加(P < 0.0001)。SFA是最常接受治疗的动脉(4751例[43.7%])。与旋切术和球囊血管成形术相比,单纯支架置入术(RR,0.36;95%CI,0.17 - 0.73;P = 0.005)、单纯球囊血管成形术(RR,0.23;95%CI,0.13 - 0.41;P < 0.0001)以及支架置入术与球囊血管成形术联合应用(RR,0.29;95%CI,0.17 - 0.49;P < 0.0001)与DE风险显著降低相关。DE与通畅性丧失、大截肢或死亡率无显著相关性。
在VSGNE数据库中,LEI期间DE的发生率为1%至2%,大多数患者接受了额外的血管内介入治疗。严重肢体缺血患者以及采用旋切术时DE的发生率会增加。